Gender and regional differences in client characteristics among substance abuse treatment clients in the Europe

Drugs: Education, Prevention and Policy

Volumn 18, Issue 1, 2011, Pages 24-31

  Montanari, Linda ^a   Serafini, Marco ^a   Maffli, Etienne ^b   Busch, Martin ^c   Kontogeorgiou, Katerina ^d   Kuijpers, Wil ^e   Ouwehand, Anton ^e   Pouloudi, Maria ^d   Simon, Roland ^a   Spyropoulou, Maria ^d   Studnickova, Bela ^f   Gyarmathy, V Anna ^a,g  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^b ADDICTION SWITZERLAND   (Switzerland)

^c Austrian Health Institute   (Austria)

^d University of Mental Health Research Institute (UMHRI)   (Greece)

^e Organization Information Systems on Addiction Care and Treatment   (Netherlands)

^f Drug Epidemiology Headquarters Hygienic Station   (Czech Republic)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952957437     PISSN: 09687637     EISSN: 14653370     Source Type: Journal    
DOI: 10.3109/09687637.2010.504199     Document Type: Article

References (25)

1. Celentano, D. D., Latimore, A. D., & Mehta, S. H. (2008). Variations in sexual risks in drug users: Emerging themes in a behavioral context. Current HIV/AIDS Report, 5, 212-218.
2. Colfax, G., & Guzman, R. (2006). Club drugs and HIV infection: A review. Clinical Infectious Disease, 42, 1463-1469.
3. Corsi, K. F., & Booth, R. E. (2008). HIV sex risk behaviors among heterosexual methamphetamine users: Literature review from 2000 to present. Current Drug Abuse Reviews, 1(3), 292-296.
4. European Commission (2005). EU drugs action plan for 2005-2008. Official Journal of the European Union, C 168, 1-18.
5. European Commission (2008). EU drugs action plan for 2009-2012. Official Journal of the European Union, C 326, 7-25.
6. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009e). Treatment demand indicator (TDI). Retrieved from http://www.emcdda.europa.eu/ themes/keyindicators/tdi
7. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2006). A gender perspective on drug use and responding to drug problems. Annual report on the state of the drugs problem in Europe 2006. Luxembourg: Office for Official Publications of the European Communities.
8. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2008). Annual report 2008: The state of the drugs problem in Europe. Luxembourg: Office for Official Publications of the European Communities.
9. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009a). Best practice portal. Retrieved from http://www.emcdda.europa.eu/best-practice
10. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (2009b). Drug treatment overviews. Retrieved from http://www.emcdda.europa.eu/responses/ treatment
11. overviews
12. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2009c). An overview of the treatment demand key indicator (TDI). Retrieved from http://www.emcdda. europa.eu/publications/methods/tdi-overview
13. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). (2009d). Reitox network. Retrieved from http://www.emcdda.europa.eu/about/ partners/reitox-network
14. Greenfield, S. F., Brooks, A. J., Gordon, S. M., Green, C. A., Kropp, F., McHugh, R. K.,..., Miele, G. M. (2007). Substance abuse treatment entry, retention, and outcome in women: A review of the literature. Drug and Alcohol Dependence, 86(1), 1-21. (Pubitemid 44708526)
15. Hernandez-Avila, C. A., Rounsaville, B. J., & Kranzler, H. R. (2004). Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug and Alcohol Dependence, 74, 265-272. (Pubitemid 38759781)
16. Iversen, E. (2009). Coverage assessment of data collected in the framework of the EMCDDA Treatment Demand Indicator. Final report. Retrieved from http://www.emcdda.europa.eu/html.cfm/index67086EN.html
17. Justice, A. J., & de Wit, H. (1999). Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berlin), 145, 67-75. (Pubitemid 29339764)
18. Sofuoglu, M., Dudish-Poulsen, S., Nelson, D., Pentel, P. R., & Hatsukami, D. K. (1999). Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Experimental and Clinical Psychopharmacology, 7, 274-283. (Pubitemid 29399031)
19. The Council of the European Union (1993). Council Regulation (EEC) No. 302/93 of 8 February 1993 on the establishment of a European Monitoring Centre for Drugs and Drug Addiction. Official Journal of the European Union, 36, 1-8.
20. The Council of the European Union (2001). Council resolution on the implementation of the five key epidemiological indicators on drugs, developed by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) (Document 12775/01 CORDROGUE 62).
21. The Council of the European Union (2006). Regulation (EC) No. 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (recast). Official Journal of the European Union, 376, 1-13.
22. van Empelen, P., Kok, G., van Kesteren, N. M., van den Borne, B., Bos, A. E., & Schaalma, H. P. (2003). Effective methods to change sex-risk among drug users: A review of psychosocial interventions. Social Science and Medicine, 57, 1593-1608. (Pubitemid 37025816)
23. Wechsberg, W. M., Luseno, W., & Ellerson, R. M. (2008). Reaching women substance abusers in diverse settings: Stigma and access to treatment 30 years later. Substance use and Misuse, 43, 1277-1279.
24. Wiechelt, S. A. (2008). Introduction to the special issue: International perspectives on women's substance use. Substance use and Misuse, 43, 973-977.
25. Zdeb, M. (2002). Maps made easy using SAS. Cary, NC: SAS Institute Inc.